drugset / Trial / NCT00282607
A Study of DA-8159 in Subjects With Erectile Dysfunction
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study will be to evaluate the clinical efficacy and safety of DA-8159, an orally administered, potent and selective inhibitor of PDE5, versus placebo for the treatment of subjects with erectile dysfunction (ED).
Timeline
- Start
- 2005-05
- Primary completion
- —
- Completion
- 2006-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Udenafil | Small molecule | — | Oral |